To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Scientific Advisory Board

Our Scientific Advisory Board makes recommendations on research priorities conducted or supported by EBCI. This includes the evaluation of EBCI awarded grants, cooperative agreements and contracts and concept review of those activities which it considers meritorious and consistent with the EBCI's programs. The advisory role of the Board is scientific and does not include deliberation on matters of public policy.

Jolene Anderson

Pat Jones photo

Pat Jones

Shannon Kavenough

Interested in Joining Our Scientific Advisory Board?


The qualifications of a member of the, Scientific and Advisory Board members may include authorities who are knowledgeable in the fields of laboratory, clinical and biometric research, clinical cancer treatment, cancer prevention and control, with emphasis on training and experience in the various disciplines and fields related to scientific areas relevant to cancer biology and diagnosis, cancer center administration, medicine, radiological and surgical oncology, cancer chemotherapy, cancer epidemiology, cancer education, cancer information services, community outreach, DNA repair and effects, tumor biology and immunology, molecular and structural biology and genetic regulation, viral oncology, vaccine development, transplantation, chemotherapy, clinical trial design, management and evaluation, pharmacology, drug development and developmental therapeutics, genetic and immunotherapies, pathology, diagnostic research and cytogenetics, biological response modifiers, imaging, nutrition, survey research, epidemiology, biostatistics, rehabilitation, psychology and behavioral medicine, public health and community oncology, quality of life, pain management, cancer detection and diagnosis, cancer treatment, nursing, public health, nutrition, education of health professionals.First and foremost, is a passion and desire to advance scientific research and outcomes to improve patient care and a willingness to extend collaborative research with other industry professionals.


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram